The 2022 PSOGI (Peritoneal Surface Oncology Group International) and RENAPE (French Network for Rare Peritoneal Malignancies) consensus on hyperthermic intraperitoneal chemotherapy (HIPEC) was a comprehensive effort aimed at standardizing treatment protocols for various peritoneal malignancies. This initiative is critical due to the wide range of technical variations in HIPEC procedures and the resulting need for standardization to ensure consistent and effective patient care and meaningful audit of multicenter data.
Keywords: HIPEC regimens; consensus; hyperthermic intraperitoneal chemotherapy; peritoneal surface malignancies.
© 2024 The Author(s). Journal of Surgical Oncology published by Wiley Periodicals LLC.